Anebulo Pharmaceuticals, Inc. Share Price & Technical Analysis
ANEB · $0.46 (-4.17%)
Healthcare / Biotechnology
$0.46
-4.17%
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
25% return in May, -18% avg return in past 3 year May month.
138% return in 2026, -3% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | -60% | 233% | -60% | 25% | – | – | – | – | – | – | – | 138% |
| 25 | -6% | -20% | 8% | -8% | -17% | 40% | 80% | -7% | 4% | 4% | -12% | -57% | 10% |
| 24 | 0% | 4% | 4% | 0% | -33% | 23% | -11% | -10% | 0% | 0% | -22% | 6% | -40% |
| 23 | 9% | 24% | -6% | 4% | -4% | 0% | -12% | 22% | 19% | -27% | -8% | 0% | 20% |
| 22 | 2% | 7% | -1% | -46% | -36% | 73% | -41% | 13% | -18% | -23% | -19% | 9% | -79% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$18.76M
P/E ratio
—
52W high
$3.42
52W low
$0.30
Volume
1,300
Beta
-1.94
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Anebulo Pharmaceuticals, Inc. share price today?
- Anebulo Pharmaceuticals, Inc. (ANEB) last traded around $0.46 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ANEB have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ANEB. Download the app for real-time alerts.
- How can I analyze Anebulo Pharmaceuticals, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.